Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies-Reference-Cited by-同舟云学术

Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies

Published:2021-07 Issue:7 Volume:29 Page:655-663.e4
ISSN:0969-2126
Container-title:Structure
language:en
Short-container-title:Structure

Author:

Cerutti Gabriele^ORCID,Rapp Micah^ORCID,Guo Yicheng^ORCID,Bahna Fabiana,Bimela Jude,Reddem Eswar R.^ORCID,Yu Jian,Wang Pengfei^ORCID,Liu Lihong,Huang Yaoxing,Ho David D.^ORCID,Kwong Peter D.^ORCID,Sheng Zizhang,Shapiro Lawrence

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference59 articles.

1. Recent developments in the PHENIX software for automated crystallographic structure determination;Adams;J. Synchrotron Radiat.,2004

2. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer;Avanzato;Cell,2020

3. Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses;Banach;bioRxiv,2021

4. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy;Barad;Nat. Methods,2015

5. Emergence of a highly fit SARS-CoV-2 variant;Baric;N. Engl. J. Med.,2020

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing pH-Dependent Conformational Changes in the Fusion Peptide Proximal Region of the SARS-CoV-2 Spike Glycoprotein;Viruses;2024-07-02

2. Assessing pH-dependent Conformational Changes in the Fusion Peptide Proximal Region of the SARS-CoV-2 spike glycoprotein;2024-05-15

3. Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein;The Journal of Physical Chemistry B;2023-09-29

4. Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants;International Journal of Biological Macromolecules;2023-09

5. Broadly neutralizing antibodies against COVID-19;Current Opinion in Virology;2023-08